CDT Equity Inc. Announces Key Results from Special Shareholder Meeting: Major Corporate Actions Approved

Date of Report: March 17, 2026

Registrant: CDT Equity Inc. (NASDAQ: CDT)

Highlights from the Special Meeting

• Approval of Share Issuance for Pre-Funded Warrants: Shareholders approved the issuance of up to 3,685,815 shares of Common Stock, par value \$0.0001 per share, upon the exercise of certain pre-funded warrants. This action is in accordance with Nasdaq Listing Rule 5635, which governs significant equity issuances and is designed to protect shareholder interests.
• Equity Line of Credit: Shareholders approved the issuance of shares of Common Stock, also under Nasdaq Listing Rule 5635, pursuant to a purchase agreement dated January 16, 2026. This agreement establishes an equity line of credit, which can provide the company with additional capital flexibility and liquidity. The number of shares that may be issued under this facility was not specified in detail, but the approval confirms shareholder support for ongoing capital raising initiatives.
• Massive Warrant Exercise Approval: Shareholders gave the green light for the issuance of up to 109,978,918 shares of Common Stock upon the exercise of certain pre-funded warrants. This is a substantial potential dilution event, representing a significant percentage of the company’s outstanding shares. The approval is again tied to compliance with Nasdaq Listing Rule 5635.
• Increase in Authorized Common Stock: Shareholders approved an amendment to the Second Amended and Restated Certificate of Incorporation to increase the number of authorized Common Stock shares from 250,000,000 to 500,000,000. This move provides the company with greater flexibility to raise capital, issue shares for acquisitions, or support other corporate actions.
• Redomestication to the Cayman Islands: Shareholders approved (A) the redomestication of CDT Equity Inc. from the State of Delaware to the Cayman Islands via conversion under Delaware law, and (B) the adoption of the memorandum and articles of association in the Cayman Islands, substantially in the form attached to the Proxy Statement. This change may have implications for the company’s tax structure, regulatory compliance, and investor protections.

Potential Share Price Sensitivities & Investor Considerations

• Significant Dilution Risk: The approval of over 109 million shares for potential issuance upon warrant exercise, and the doubling of authorized shares, may lead to substantial dilution for existing shareholders if these securities are issued. Investors should carefully monitor the company’s capital raising activities and their impact on earnings per share, voting power, and share price.
• Redomestication Impact: Moving the corporate domicile from Delaware to the Cayman Islands could affect the company’s tax obligations, legal protections for shareholders, and regulatory requirements. Such a change could be viewed positively (e.g., tax efficiency) or negatively (e.g., weaker shareholder rights), depending on the details.
• Capital Raising & Liquidity: The equity line of credit and warrant exercises suggest the company may need or want additional capital. While this can support growth, it may also signal liquidity needs or future investment requirements.
• Emerging Growth Company Status: CDT Equity Inc. is classified as an emerging growth company under Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934. This status allows the company to take advantage of reduced reporting requirements and extended transition periods for new accounting standards (though CDT Equity Inc. has not elected to use the extended transition period).
• Shareholder Voting Results: All proposals, including those for significant share issuances and corporate structural changes, were approved by the shareholders. This strong mandate may indicate broad shareholder support for management’s strategic direction.

Shareholder Actions & Next Steps

• Monitor Public Filings: Investors should watch for further SEC filings that provide details on the timing and terms of any share issuances, warrant exercises, or capital raising transactions.
• Evaluate Impact of Redomestication: Shareholders should review the new charter and articles of association for any changes in their rights and protections.
• Stay Alert for Price Volatility: The scale of authorized share increases and warrant exercises could create share price volatility, especially if the market perceives dilution risk or changes in corporate governance standards.

Trading Information

• Common Stock: NASDAQ: CDT
• Redeemable Warrants: NASDAQ: CDTTW (each whole warrant exercisable for one share of Common Stock)

Disclaimer

This article is provided for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All information is based on publicly available filings and may be subject to change. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. CDT Equity Inc.’s actions described above may have significant implications for share value, and past performance is not indicative of future results.

View CDT Equity Inc. Historical chart here